CanSinoBIO's mRNA Covid-19 vaccine candidate cleared for trials in China

Published: Apr 4, 2022 2:25 AM

Chinese vaccine developer CanSino Biologics Inc (CanSinoBIO) said on Monday its potential Covid-19 vaccine using the messenger RNA (mRNA) technology has been approved by China's medical products regulator to enter clinical trials.

Unlike other major countries, China has yet to approve any foreign-made mRNA vaccines such as those produced by US-German duo Pfizer Inc and BioNTech SE.

With around 88 percent of its 1.4 billion population already vaccinated, China is...

China sends military, doctors to Shanghai to test 26 million residents for Covid

Shanghai expands Covid lockdown as new daily cases surge by a third

China truckers use fake travel records, 'clean' drivers to dodge Covid-19 rules

Bankers sleep in offices to beat Shanghai Covid lockdown

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: